Selective alteration of personality and social behavior by serotonergic intervention

American Journal of Psychiatry

Volumn 155, Issue 3, 1998, Pages 373-379

  Knutson, Brian ^a   Wolkowitz, Owen M ^a   Cole, Steve W ^a   Chan, Theresa ^a   Moore, Elizabeth A ^a   Johnson, Ronald C ^a   Terpstra, Jan ^a   Turner, Rebecca A ^a   Reus, Victor I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; PLACEBO; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

AFFECT; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HOSTILITY; HUMAN; NORMAL HUMAN; PERSONALITY; PRIORITY JOURNAL; PSYCHOMETRY; SEROTONINERGIC SYSTEM; SEXUAL DYSFUNCTION; SOCIAL BEHAVIOR; SOCIAL INTERACTION; SOMNOLENCE; SYMPTOMATOLOGY;

EID: 0031894504     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.155.3.373     Document Type: Article

References (38)

1. Digman JM: Personality structure: emergence of the five-factor model. Annu Rev Psychol 1990; 41:417-440
2. Costa PT Jr, McCrae RR: Set like plaster: evidence for the stability of adult personality, in Can Personality Change? Edited by Heatherton TF, Weinberger JL. Washington, DC, American Psychological Association, 1994, pp 21-40
3. Bouchard TJ Jr: Genes, environment, and personality. Science 1994; 264:1700-1701
4. Cloninger CR: A systematic method for clinical description and classification of personality variants: a proposal. Arch Gen Psychiatry 1987; 44:573-588
5. Depue RA, Luciana M, Arbisi P, Collins P, Leon A: Dopamine and the structure of personality: relation of agonist-induced dopamine activity to positive emotionality. J Pers Soc Psychol 1994; 67:485-498
6. Zuckerman M: Good and bad humors: biochemical bases of personality and its disorders. Psychol Science 1995; 6:325-332
7. Virkkunen M, Rawlings R, Tokola R, Poland RE, Guidotti A, Nemeroff C, Bissette G, Kalogeras K, Karonen SL, Linnoila M: CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry 1994; 51:20-27
8. Coccaro EF, Kavoussi RJ: Neurotransmitter correlates of impulsive aggression, in Aggression and Violence: Genetic, Neurobiological, and Biosocial Perspectives. Edited by Stoff DM, Cairns RB. Hillsdale, NJ, Lawrence Erlbaum Associates, 1996, pp 67-85
9. Fuller RW: The influence of fluoxetine on aggressive behavior. Neuropsychopharmacology 1996; 14:77-81
10. Ellenbogen MA, Young SN, Dean P, Palmour RM, Benkelfat C: Mood response to acute tryptophan depletion in healthy volunteers: sex differences and temporal stability. Neuropsychopharmacology 1996; 15:465-474
11. Smith SE, Pihl RO, Young SN, Ervin FR: A test of possible cog nitive and environmental influences on the mood lowering effect of tryptophan depletion in normal males. Psychopharmacology (Berl) 1987; 91:451-457
12. Moeller FG, Dougherty DM, Swann AC, Collins D, Davis CM, Cherek DR: Tryptophan depletion and aggressive responding in healthy males. Psychopharmacology (Berl) 1996; 126:97-103
13. Cleare AJ, Bond AJ: The effect of tryptophan depletion and enhancement on subjective and behavioral aggression in normal male subjects. Psychopharmacology (Berl) 1995; 118:72-81
14. Higley JD, Mehlman PT, Higley SB, Fernald B, Vickers J, Lindell SG, Taub DM, Suomi SJ, Linnoila M: Excessive mortality in young free-ranging male nonhuman primates with low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration. Arch Gen Psychiatry 1996; 53:537-543
15. Higley JD, King ST Jr, Hasert MF, Champoux M, Suomi SJ, Linnoila M: Stability of interindividual differences in serotonin function and its relationship to severe aggression and competent social behavior in rhesus macaque females. Neuropsychopharmacology 1996; 14:67-76
16. Mehlman PT, Higley JD, Faucher I, Lilly AA, Taub DM, Vickers J, Suomi SJ, Linnoila M: Correlation of CSF 5-HIAA concentration with socialty and the timing of emigration in free-ranging primates. Am J Psychiatry 1995; 152:907-913
17. Raleigh JM, Brammer GL, Ritvo ER, Geller E, McGuire MT, Yuwiler A: Effects of chronic fenfluramine on blood serotonin, cerebrospinal fluid metabolites, and behavior in monkeys. Psychopharmacology (Berl) 1988; 90:503-508
18. Raleigh MJ: Differential behavioral effects of tryptophan and 5-hydroxytryptophan in vervet monkeys: influence of catecholaminergic systems. Psychopharmacology (Berl) 1987; 93:44-50
19. Raleigh MJ, McGuire MT, Brammer GL, Pollack DB, Yuwiler A: Serotonergic mechanisms promote dominance acquisition in adult male vervet monkeys. Brain Res 1991; 559:181-190
20. Hyttel J: Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 1994; 9(suppl 1):19-26
21. Carlson JN, Visker KE, Nielsen DM, Keller RW Jr, Click SD: Chronic antidepressant drug treatment reduces turning behavior and increases dopamine levels in the medial prefrontal cortex. Brain Res 1996; 707:122-126
22. Spitzer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Interview for DSM-III-R - Non-Patient Edition (SCID-NP, Version 1.0). Washington, DC, American Psychiatric Press, 1990
23. Buss AH, Durkee A: An inventory for assessing different kinds of hostility. J Consult Psychol 1957; 21:343-349
24. Siever L, Trestman RL: The serotonin system and aggressive personality disorder. Int Clin Psychopharmacol 1993; 8(suppl 2): 33-39
25. Watson D, Clark LA, Tellegen A: Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 1988; 54:1063-1070
26. Brett MA, Dierdorf HD, Zussman BD, Coates PE: Determination of paroxetine in human plasma, using high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987; 419:438-444
27. Rogosa DR, Willett JB: Understanding correlates of change by modeling individual differences in growth. Psychometrika 1985; 50:203-208
28. Baron RM, Kenny DA: The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986; 51:1173-1182
29. Coccaro EF: Impulsive aggression and central serotonergic system function in humans: an example of a dimensional brain-behavior relationship. Int J Psychopharmacol 1992; 7:3-12
30. Tellegen A: Structures of mood and personality and their relevance to assessing anxiety, with an emphasis on self-report, in Anxiety and the Anxiety Disorders. Edited by Tuma AH, Maser J, Hillsdale, NJ, Lawrence Erlbaum Associates, 1985, pp 681-706
31. Depue RA, Luciana M, Arbisi P, Collins P, Leon A: Dopamine and the structure of personality: relation of agonist-induced dopamine activity to positive emotionality. J Pers Soc Psychol 1994; 67:485-498
32. Raleigh MJ, Brammer GL, McGuire MT, Yuwiler A: Dominant social status facilitates the behavioral effects of serotonergic agonists. Brain Res 1985; 348:274-282
33. Knutson B, Panksepp J: Effects of fluoxetine treatment on play dominance in juvenile rats. Aggressive Behavior 1996; 22:297-307
34. van Harten J: Clinical pharmacokinetics of selective serotonin reuptake inhibitors. Clin Pharmacokinet 1993; 24:203-220
35. Katz MM, Maas JW, Frazer A, Koslow SH, Bowden CL, Berman N, Swann AC, Stokes PE: Drug-induced actions on brain neurotransmitter systems and changes in the behaviors and emotions of depressed patients. Neuropsychopharmacology 1994; 11:89-100
36. Barr LC, Heninger GR, Goodman W, Charney DS, Price LH: Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects. Biol Psychiatry 1997; 41:949-954
37. Lesch K-P, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL: Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274:1527-1531
38. Klein DF: Anxiety reconceptualized: gleaning from pharmacological dissection: early experience with imipramine and anxiety. Mod Probl Pharmacopsychiatry 1987; 22:1-35